Publications | Page 3 | Cervo Brain Research Centre

Export 69 results:

Filters: Author is Jasna Kriz [Clear All Filters]

2009

J. Kriz and Lalancette-Hébert, M., “Inflammation, plasticity and real-time imaging after cerebral ischemia.”, Acta Neuropathol, vol. 117, no. 5, pp. 497-509, 2009.

F. A Keller, Gravel, M., and Kriz, J., “Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.”, Glia, vol. 57, no. 10, pp. 1130-42, 2009.

2008

F. Gros-Louis, Kriz, J., Kabashi, E., McDearmid, J., Millecamps, S., Urushitani, M., Lin, L., Dion, P., Zhu, Q., Drapeau, P., J-P Julien, and Rouleau, G. A., “Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish.”, Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.

P. Cordeau, Lalancette-Hébert, M., Weng, Y. Cheng, and Kriz, J., “Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury.”, Stroke, vol. 39, no. 3, pp. 935-42, 2008.

2007

J-P Julien and Kriz, J., “Chapter 6 Animal models of motor neuron death.”, Handb Clin Neurol, vol. 82, pp. 121-38, 2007.

Y. Cheng Weng and Kriz, J., “Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia.”, Exp Neurol, vol. 204, no. 1, pp. 433-42, 2007.

D. Maysinger, Behrendt, M., Lalancette-Hébert, M., and Kriz, J., “Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles.”, Nano Lett, vol. 7, no. 8, pp. 2513-20, 2007.

M. Lalancette-Hébert, Gowing, G., Simard, A., Weng, Y. Cheng, and Kriz, J., “Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.”, J Neurosci, vol. 27, no. 10, pp. 2596-605, 2007.

2006

J. Kriz, “Inflammation in ischemic brain injury: timing is important.”, Crit Rev Neurobiol, vol. 18, no. 1-2, pp. 145-57, 2006.

J-P Julien and Kriz, J., “Transgenic mouse models of amyotrophic lateral sclerosis.”, Biochim Biophys Acta, vol. 1762, no. 11-12, pp. 1013-24, 2006.

2005

J-P Julien, Millecamps, S., and Kriz, J., “Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).”, Novartis Found Symp, vol. 264, pp. 183-92; discussion 192-6, 227-30, 2005.

J. Kriz, Beaulieu, J. - M., J-P Julien, and Krnjević, K., “Up-regulation of peripherin is associated with alterations in synaptic plasticity in CA1 and CA3 regions of hippocampus.”, Neurobiol Dis, vol. 18, no. 2, pp. 409-20, 2005.

2003

M. Dang Nguyen, Boudreau, M., Kriz, J., Couillard-Després, S., Kaplan, D. R., and J-P Julien, “Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.”, J Neurosci, vol. 23, no. 6, pp. 2131-40, 2003.

J. Kriz, Zupan, G., and Simonić, A., “Differential effects of dihydropyridine calcium channel blockers in kainic acid-induced experimental seizures in rats.”, Epilepsy Res, vol. 52, no. 3, pp. 215-25, 2003.

J. Kriz, Gowing, G., and J-P Julien, “Efficient three-drug cocktail for disease induced by mutant superoxide dismutase.”, Ann Neurol, vol. 53, no. 4, pp. 429-36, 2003.

J. Kriz and Padjen, A. L., “Intra-axonal recording from large sensory myelinated axons: demonstration of impaired membrane conductances in early experimental diabetes.”, Diabetologia, vol. 46, no. 2, pp. 213-21, 2003.

2002

J. - M. Beaulieu, Kriz, J., and J-P Julien, “Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia.”, Brain Res, vol. 946, no. 2, pp. 153-61, 2002.

J. Kriz, Nguyen, M. Dang, and J-P Julien, “Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.”, Neurobiol Dis, vol. 10, no. 3, pp. 268-78, 2002.

J. Robertson, Kriz, J., Nguyen, M. Dang, and J-P Julien, “Pathways to motor neuron degeneration in transgenic mouse models.”, Biochimie, vol. 84, no. 11, pp. 1151-60, 2002.

Funding / Support / Partners

© Gouvernement du Québec